| Date Filed | Type | Description |
| 01/05/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 01/05/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 01/05/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 01/04/2011 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 01/04/2011 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 01/04/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/15/2010 |
8-K
| Quarterly results |
| 12/14/2010 |
BW
| Osteologix Announces Plans to Deregister Company Common Stock and Initiate Corporate Consolidation |
| 11/15/2010 |
10-Q
| Quarterly Report for the period ended September 30, 2010 |
| 10/18/2010 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 10/08/2010 |
8-K
| Form 8-K - Current report |
| 08/16/2010 |
10-Q
| Quarterly Report for the period ended June 30, 2010 |
| 08/02/2010 |
8-K
| Form 8-K - Current report |
| 06/15/2010 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 06/14/2010 |
D
| Form D - Notice of Exempt Offering of Securities |
| 06/11/2010 |
4
| Hansen Christian (10% Owner) has filed a Form 4 on Osteologix, Inc.|
Txns:
| Bought 1,494,532 shares
@ $0.5018, valued at
$750k
|
|
| 06/11/2010 |
4
| Schonharting Florian (10% Owner) has filed a Form 4 on Osteologix, Inc.|
Txns:
| Bought 1,494,532 shares
@ $0.5018, valued at
$750k
|
|
| 06/11/2010 |
4
| Nordic Biotech General Partner ApS (10% Owner) has filed a Form 4 on Osteologix, Inc. |
| 06/11/2010 |
SC 13D/A
| Nordic Biotech K/S reports a 65.9% stake in Osteologix, Inc. |
| 06/11/2010 |
8-K
| Form 8-K - Current report |
| 05/17/2010 |
10-Q
| Quarterly Report for the period ended March 31, 2010 |
| 04/30/2010 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 04/30/2010 |
10-K/A
| Annual Report for the period ended December 31, 2009 [amend] |
| 03/31/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
| 02/16/2010 |
SC 13G/A
| BURLINGAME ASSET MANAGEMENT, LLC reports a 7.4% stake in Osteologix, Inc. |
| 02/04/2010 |
8-K/A
| Form 8-K - Current report [amend] |
| 02/03/2010 |
4
| BARBERICH JOHN M. (Chairman of the Board) has filed a Form 4 on Osteologix, Inc. |
| 02/03/2010 |
3
| BARBERICH JOHN M. (Chairman of the Board) has filed a Form 3 on Osteologix, Inc. |
| 02/03/2010 |
DEF 14C
| Form DEF 14C - Other definitive information statements |
| 01/29/2010 |
4
| Young Philip J (CEO and President) has filed a Form 4 on Osteologix, Inc. |
| 01/29/2010 |
4
| Sandage Bobby W JR (Director) has filed a Form 4 on Osteologix, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.71, valued at
$28.4k
|
|
| 01/29/2010 |
4
| Eldrup-Jorgensen Klaus (Director) has filed a Form 4 on Osteologix, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.71, valued at
$28.4k
|
|
| 01/29/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/28/2010 |
D
| Form D - Notice of Exempt Offering of Securities |
|